Previous Seminars
23 Jan 2012
Assoc. Prof. Jan Pravsgaard Christensen, University of Copenhagen
Improved immunogenicity of adenoviral vaccines: Impact of tethering the vaccine antigen to MHC-class II associated invariant chain
1 Dec 2011
Dr Javier Castillo-Olivares, Institute for Animal Health
Recombinant DNA vaccines for exotic equine viral diseases: Equine viral arteritis and African horse sickness
24 Nov 2011
Prof Gavin Wilkinson, Cardiff University School of Medicine
Revisiting and Re-engineering Adenovirus Vectors
22 Nov 2011
Dr Laura Martin, Development Project Leader for monovalent Typhi and bivalent Typhi/Paratyphi A vaccines, Novartis Vaccines Institute for Global Health (NVGH), Siena
NVGH’s development of enteric fever vaccines
7 Nov 2011
Prof Quentin Sattentau, The William Dunn School of Pathology, University of Oxford
Mucosal adjuvants for HIV vaccines
27 Oct 2011
Dr Martin Bachmann, CSO of Cytos Biotechnology, Switzerland
Vaccines against addictions
7 Sept 2011
Dr Andreas Neubert, Vice-President Vaccines, IDT Biologika, Germany
Vaccine development - hurdles and chances for new approaches and technologies
22 Aug 2011
Prof James Brewer, Institute of Infection, Immunity & Inflammation, University of Glasgow
Imaging the immune system in vivo
15 July 2011
Prof Peter J. Hotez, President of the Sabin Vaccine Institute
The “Antipoverty Vaccines” for the Neglected Tropical Diseases
10 June 2011
Prof David Lewinsohn, Portland VA Medical Center
Immune Recognition of the Mtb Infected Cell
18 April 2011
Prof Robin Shattock, St George's, London
Vaccine strategies for focusing humoral immune response on the mucosal portal of HIV entry
21 Feb 2011
Prof Sir Marc Feldmann, Kennedy Institute of Rheumatology, Imperial College London
Anti-TNF therapy : past, present and future
13 Jan 2011
Dr Allan Saul, Novartis Vaccines Institute for Global Health, Siena
New Vaccines for Enteric Pathogens
10 Dec 2010
Prof Bali Pulendran, Emory Vaccine Center, Emory University
Systems biological approaches to vaccinology
7 Sept 2010
Prof Robert Sinden, Imperial College London and University of Oxford
Malaria transmission blocking vaccines: Sex, lies & videotapes - 2 out of 3, or 3 out of 3?
6 July 2010
Prof Paul Griftiths, Centre for Virology, University College London Medical School
Progress towards vaccines against human cytomegalovirus
4 June 2010
Prof Mary Collins, Dean of the Faculty of Life Sciences, University College London
Regulating dendritic cell signalling to improve vaccination
18 May 2010
Prof Glyn Hewinson, Veterinary Laboratories Agency
TB Vaccines for Badgers and Cattle: No More Mr. Ten Years!
20 April 2010
Prof Paul Fine, Professor of Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
Vaccines, herd immunity and eradication programmes
16 Mar 2010
Prof Andy Morgan, Department of Cellular & Molecular Medicine, University of Bristol
Progress in the development of vaccines for Epstein-Barr virus and its associated diseases
14 Jan 2010
Dr Ed Lavelle, School of Biochemistry & Immunology, Trinity College Dublin
Particulate adjuvants for parenteral and mucosal vaccines
16 Oct 2009
Prof Dan Barouch, Division of Vaccine Research, Harvard University
Novel Vectors and Antigens for an HIV Vaccine
21 Sept 2009
Dr Marie-Paule Kieny, Director, WHO Initiative for Vaccine Research
Vaccine Research and International Health
19 Aug 2009
Prof Ian Orme, Colorado State University, College of Veterinary Medicine & Biomedical Sciences
TB: Two scary stories and one marginally disturbing...
14 July 2009
Prof Mark Kendall, University of Queensland, Australian Institute for Bioengineering and Nanotechnology
Nanopatches: targeted delivery to skin for improved vaccines
16 June 2009
Prof Paul Kaye, University of York, Centre for Immunology and Infection
Therapeutic vaccines for leishmaniasis: lessons from pathology
12 May 2009
Prof Alan Rickinson, University of Birmingham, School of Cancer Sciences
Prospects for therapeutic vaccines against Epstein-Barr virus-associated tumours
21 April 2009
Dr Satya Parida, Institute for Animal Health, FMD Vaccine Differentiation Group
Vaccination against FMDV: strategies and effectiveness
17 March 2009
Prof Sarah Rowland-Jones, MRC and Weatherall Institute for Molecular Medicine, University of Oxford
What can HIV-2 teach us about protective immunity in HIV infection?
13 Jan 2009
Dr Dirk Werling, Royal Veterinary College, Dept. of Pathology & Infectious Diseases
Structure-function relationships of Toll-like receptor domains in different species and their potential impact on vaccine design
7 Oct 2008
Dr Rachel Midgley, Department of Clinical Pharmacology, University of Oxford
Cancer Vaccines - Principles and Practice
9 Sept 2008
Prof Albert Osterhaus, Erasmus MC, University of Rotterdam
Influenza Vaccines
26 Aug 2008
Dr David Lewinsohn, Oregon Health & Science University, Molecular Microbiology and Immunology
Recognition of Intracellular Infection with Mtb: The Human CD8 Response to Tuberculosis
8 July 2008
Prof John Hermon-Taylor, School of Biomedical and Health Sciences, King's
College London
A tutorial on paratuberculosis: New insights into human disease
17 June 2008
Dr Robert Harrison, Alistair Reid Venom Research Unit, Liverpool School of Tropical Medicine
New strategies to improve an old therapy - snake antivenom
20 May 2008
Prof Dave Stuart, Division of Structural Biology, University of Oxford)
Foot and mouth disease virus - structure and vaccine design
8 April 2008
Prof Declan McKeever, Royal Veterinary College
19 Feb 2008
Dr Paul Klenerman, Peter Medawar Building for Pathogen Research, University of Oxford)
HCV Vaccines - Demand and Supply
22 Jan 2008
Prof Jonathan Heeney, Comparative Pathology, University of Cambridge
"What Jenner didn't know": Poxviruses which differentially induce CD4 or CD8 T-cells and immunity
11 Dec 2007
Dr John Shiver, Vice President Vaccines and Biologics Research, Merck
Merck's HIV Vaccine Programme
6 Nov 2007
Prof Mark Stephens (IAH)
Toward control of food-borne diarrhoeal pathogens
2 Oct 2007
Prof John Oxford, Oxford
Volunteers for influenza quarantine experiments: from the 1918 pandemic
26 Jun 2007
Dr Lucy Dorrell, Compton
Therapeutic HIV vaccines
29 May 2007
Dr Venugopal Nair, Oxford
Marek's disease: a natural lymphoma controlled by vaccination
24 Apr 2007
Dr Linda Dixon, Oxford
Strategies to produce African swine fever vaccines
13 Mar 2007
Prof Richard Moxon, Compton
The challenge of the meningococcus
27 Feb 2007
Dr Tom Barrett, Oxford
Rinderpest and PPR vaccines: how can they be improved?
23 Jan 2007
Dr Sarah Gilbert, Compton
Replication-deficient viral vaccines
13 Dec 2006
Prof Andrew McMichael, Compton
HIV vaccine design
12 Dec 2006
Dr Adrian Smith, Oxford
Protective immunity to intracellular infection in the gut: where, how and what is important?
21 Nov 2006
Prof Vincenzo Cerundolo, Compton
Harnessing NKT cells in vaccination strategies
24 Oct 2006
Dr Jayne Hope, Oxford
Dendritic cells and immune responses to bovine TB
21 Sep 2006
Dr Tomas Hanke, Compton
HIV vaccine development
02 May 2006
Prof Quentin Sattentau, Compton
The role of reactive carbonyls in vaccine hypersensitivity
11 Apr 2006
Dr Helen McShane, Compton
Developing a better TB vaccine: clinical trials with MVA85A
04 Apr 2006
Dr Jim Kaufman, Oxford
Avian influenza: the bird’s eye view
14 Mar 2006
Dr Andrew Pollard, Compton
B cell responses to conjugate vaccines in infants
07 Mar 2006
Dr Geraldine Taylor, Oxford
Bovine RSV vaccines
14 Feb 2006
Martin Maiden, Compton
Vaccines against meningococcal disease
07 Feb 2006
Dr David Paton & Dr Bryan Charleston, Oxford
Foot and mouth disease virus: strategies to improve vaccines
08 Nov 2005
Prof Adrian Hill, Compton
Developing malaria vaccines: bench to bush
01 Nov 2005
Sir Gustav Nossal (Opening Symposium), Oxford
Developing country health post-Gleneagles
